US Pharma MarketingExpanding its biopharma plans, Anthropic looks for a life sciences dealmaker
Anthropic posts a corporate development role for life sciences dealmaking, paying up to $600,000, as its biotech push and IPO plans both take shape. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing:…
Anthropic's newest job posting confirms the company's biotech dealmaking ambitions.
The San Francisco tech giant is hiring for a corporate development lead in biopharma to “source and execute acquisitions, investments, and strategic partnerships with AI-native ...
Source: Endpoints News